First American Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,828
| Closed | -$1.04M | – | 243 |
|
2024
Q4 | $1.04M | Sell |
2,828
-26,132
| -90% | -$9.64M | 0.1% | 119 |
|
2024
Q3 | $15.1M | Sell |
28,960
-2,150
| -7% | -$1.12M | 1.49% | 15 |
|
2024
Q2 | $16.9M | Buy |
31,110
+7,913
| +34% | +$4.29M | 1.69% | 12 |
|
2024
Q1 | $12M | Buy |
23,197
+2,751
| +13% | +$1.43M | 1.26% | 17 |
|
2023
Q4 | $9.64M | Sell |
20,446
-1,304
| -6% | -$615K | 1.19% | 21 |
|
2023
Q3 | $9.47M | Buy |
21,750
+6,254
| +40% | +$2.72M | 1.34% | 20 |
|
2023
Q2 | $6.88M | Buy |
15,496
+200
| +1% | +$88.8K | 0.95% | 36 |
|
2023
Q1 | $7.03M | Sell |
15,296
-5,694
| -27% | -$2.62M | 1.04% | 36 |
|
2022
Q4 | $10.8M | Buy |
20,990
+356
| +2% | +$183K | 1.67% | 14 |
|
2022
Q3 | $9.37M | Buy |
20,634
+207
| +1% | +$94K | 1.57% | 16 |
|
2022
Q2 | $9.86M | Sell |
20,427
-5,376
| -21% | -$2.59M | 1.56% | 16 |
|
2022
Q1 | $12.7M | Buy |
25,803
+1,425
| +6% | +$700K | 1.75% | 15 |
|
2021
Q4 | $11.3M | Buy |
24,378
+784
| +3% | +$363K | 1.54% | 19 |
|
2021
Q3 | $8.8M | Buy |
23,594
+1,088
| +5% | +$406K | 1.33% | 20 |
|
2021
Q2 | $8.59M | Sell |
22,506
-915
| -4% | -$349K | 1.35% | 18 |
|
2021
Q1 | $8.41M | Buy |
23,421
+594
| +3% | +$213K | 1.33% | 19 |
|
2020
Q4 | $7.33M | Buy |
22,827
+2,493
| +12% | +$800K | 1.22% | 21 |
|
2020
Q3 | $5.46M | Buy |
20,334
+485
| +2% | +$130K | 0.98% | 37 |
|
2020
Q2 | $5.22M | Buy |
19,849
+932
| +5% | +$245K | 1.02% | 31 |
|
2020
Q1 | $4.3M | Buy |
18,917
+8,526
| +82% | +$1.94M | 1.05% | 31 |
|
2019
Q4 | $3.14M | Buy |
+10,391
| New | +$3.14M | 0.6% | 64 |
|